how many mg ghk cu per day 7% GHK-CU ACCELERANT GHK-Cu Peptides Before and After:

It is extra work

The key findings from this clinical program include significant reductions in body weight and fat mass in treatment groups compared to placebo, preferential loss of abdominal and visceral adipose tissue, no changes in serum IGF-1 levels at any dose tested, no negative effects on glucose metabolism or insulin sensitivity, no significant adverse events related to metabolic or endocrine disruption, and safety profile indistinguishable from placebo for most parameters

By using senolytics to remove senescent endothelial and smooth muscle cells, combined with senomorphics like rapamycin to modulate the SASP, this dual approach could reduce arterial stiffness, improve vascular function, and lower the risk of heart attacks and stroke.211,212 Neurodegenerative Diseases: Conditions like Alzheimers disease, Parkinsons disease, and other forms of dementia are characterized by neuroinflammation and the accumulation of senescent cells in the brain.26 Combination therapies targeting both senescent cells and the neuroinflammatory SASP could slow disease progression, improve cognitive function, and promote neuronal repair.213 Senolytics like dasatinib and quercetin, combined with senomorphic agents such as NMN, could help rejuvenate neuronal tissue and prevent cognitive decline.214 Osteoporosis and Sarcopenia: Aging is associated with a decline in bone density and muscle mass, partly driven by the accumulation of senescent cells in bone and muscle tissue

The quality controls of GHK and these two targeting peptides are shown in Supplementary Figure S1

Research into its anti-tumour potential in breast and colorectal cancer has been prompted by its alleged antioxidant activities and potential to decrease carcinogenic receptor expression